| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/10/2011 | WO2011016775A1 A sensor element |
| 02/10/2011 | WO2011016743A1 New molecular modeling methods, related methods, software, systems, and products |
| 02/10/2011 | WO2011016565A1 Nucleic acid element for use in analysis, and analytical method, analytical reagent and analytical instrument using same |
| 02/10/2011 | WO2011016461A1 Tumor angiogenesis inhibitor |
| 02/10/2011 | WO2011016382A1 Biomolecule fixing board and method of manufacturing the same |
| 02/10/2011 | WO2011016326A1 Method for detecting prozone phenomenon, analysis method, device for detecting prozone phenomenon and analyzer |
| 02/10/2011 | WO2011016308A1 Component measuring device |
| 02/10/2011 | WO2011016239A1 Antibodies that specifically bind to a beta oligomers and use thereof |
| 02/10/2011 | WO2011016238A1 Antibodies that specifically bind to a beta oligomers and use thereof |
| 02/10/2011 | WO2011016189A1 Technique for classifying cells, image processing program and image processing device using the technique, and method for producing cell mass |
| 02/10/2011 | WO2011016061A1 Apparatus for determining the residual quantity of polluting agents in a gas mixture and process for determining such quantity |
| 02/10/2011 | WO2011016031A2 Urinary biomarkers for cancer diagnosis |
| 02/10/2011 | WO2011015870A1 Bilayers |
| 02/10/2011 | WO2011015864A1 Assay |
| 02/10/2011 | WO2011015754A1 Method for predicting a physical interaction effect between a tire and a surface course |
| 02/10/2011 | WO2011015631A1 Method of identifying micro-organisms and their species in blood culture |
| 02/10/2011 | WO2011015593A1 Methods and compounds for the diagnosis and treatment of cancer |
| 02/10/2011 | WO2011015589A1 Method of evaluating cancer risk in human |
| 02/10/2011 | WO2011015573A1 Molecular targets and compounds, and methods to identify the same, useful in the treatment of neurodegenerative diseases |
| 02/10/2011 | WO2011015572A1 Molecular targets and compounds, and methods to identify the same, useful in the treatment of neurodegenerative diseases |
| 02/10/2011 | WO2011015521A1 Beta cell marker antibody |
| 02/10/2011 | WO2011015446A1 Method for the detection of renal damage |
| 02/10/2011 | WO2011015381A1 Method for prognosis of pulmonary arterial hypertension by detecting anti-par1-antibodies |
| 02/10/2011 | WO2011015380A1 Method for prognosis of pulmonary arterial hypertension by detecting anti-par2-antibodies |
| 02/10/2011 | WO2011015379A1 Human hcv-interacting proteins and methods of use |
| 02/10/2011 | WO2011015359A1 Bioanalytical device |
| 02/10/2011 | WO2011015353A2 Portable handheld medical diagnostic devices |
| 02/10/2011 | WO2011015325A1 Fructosyl peptidyl oxidase and sensor for assaying a glycated protein |
| 02/10/2011 | WO2011015294A1 Device for processing rapid polymeric reaction systems |
| 02/10/2011 | WO2011015131A1 Immunoassay chip for fish lymphocystis disease virus, preparation method and application thereof |
| 02/10/2011 | WO2011014947A1 Porphyromonas gingivalis polypeptides |
| 02/10/2011 | WO2011014946A1 Cell concentration, capture and lysis devices and methods of use thereof |
| 02/10/2011 | WO2011014945A1 Method for determining the presence and concentration of analytes using a nucleic acid ligand and rare earth element |
| 02/10/2011 | WO2011014898A1 Method for continuously determining the concentration of at least one cn compound in an aqueous solution |
| 02/10/2011 | WO2010148323A3 Diagnosis and treatment of diseases or disorders associated with xenotropic murine leukemia virus-related virus |
| 02/10/2011 | WO2010144799A3 Methods and compositions for diagnostic assays for measuring cell mediated immune response |
| 02/10/2011 | WO2010144482A3 Systems and methods for the identification of compounds in medical fluids using admittance spectroscopy |
| 02/10/2011 | WO2010138024A3 Agent for protecting brain cells |
| 02/10/2011 | WO2009158618A8 Avian reoviridae |
| 02/10/2011 | US20110035820 Tomato hybrid ps01819578 |
| 02/10/2011 | US20110035818 Diagnostic marker and platform for drug design in myocardial infarction and heart failure |
| 02/10/2011 | US20110035817 Siva 3, its preparation and use |
| 02/10/2011 | US20110035816 Genetically Modified Rat Models for Drug Metabolism |
| 02/10/2011 | US20110035815 Mosaic knockout mouse tumor models and methods or use |
| 02/10/2011 | US20110035158 Methods of and devices for monitoring the effects of cellular stress and damage resulting from radiation exposure |
| 02/10/2011 | US20110035157 Biomass concentration measurement device and method and use of an electronic chip element for measuring said biomass concentration |
| 02/10/2011 | US20110035156 Method of evaluating gastric cancer, gastric cancer-evaluating apparatus, gastric cancer-evaluating method, gastric cancer-evaluating system, gastric cancer-evaluating program and recording medium |
| 02/10/2011 | US20110035155 Protein aggregation prediction systems |
| 02/10/2011 | US20110034682 Oligonucleotide sequence formula for labeling olignucleotide probes and proteins for in-situ analysis |
| 02/10/2011 | US20110034562 Psycho-pharmaceuticals |
| 02/10/2011 | US20110034522 Methods for alleviating deleterious effects of 3-deoxyglucosone |
| 02/10/2011 | US20110034488 Method of assaying 5-fu |
| 02/10/2011 | US20110034438 Structural mimetics of proline-rich peptides and the pharmaceutical use thereof |
| 02/10/2011 | US20110034400 Compositions and methods for analyzing bacterial adherence and anti-adherence to mucus, epithelial cells and other cells |
| 02/10/2011 | US20110034398 Use of imp3 as a prognostic marker for cancer |
| 02/10/2011 | US20110034383 Cxcl12 gamma a chemokine and uses thereof |
| 02/10/2011 | US20110034372 Truncated activin type ii receptor and methods of use |
| 02/10/2011 | US20110034370 Bis-met histones |
| 02/10/2011 | US20110034369 Agonists of Bitter Taste Receptors and Uses Thereof |
| 02/10/2011 | US20110034344 Response gene to complement 32 (rgc-32) in disease |
| 02/10/2011 | US20110034343 Method and apparatus for detecting elution of samples |
| 02/10/2011 | US20110033954 Biofunctionalized quantum dots for biological imaging |
| 02/10/2011 | US20110033953 Characterization of reaction variables |
| 02/10/2011 | US20110033952 Sensor for Biomolecules |
| 02/10/2011 | US20110033951 Assay method and kit for nucleic acid binding protein |
| 02/10/2011 | US20110033950 Turbidimetric immunoassay for assessing human cystatin c |
| 02/10/2011 | US20110033946 Detection of short-chain fatty acids in biological samples |
| 02/10/2011 | US20110033944 Method for measuring hypochlorite ion |
| 02/10/2011 | US20110033943 Hydrogen sulphide sampling method |
| 02/10/2011 | US20110033942 Predicting renal failure in diabetes patients based on placental growth factor and soluble flt-1 |
| 02/10/2011 | US20110033941 Risk analysis in patients with and without metabolic syndrome |
| 02/10/2011 | US20110033940 Click chemistry, molecular transport junctions, and colorimetric detection of copper |
| 02/10/2011 | US20110033939 Method of measuring lipoarabinomannan and application thereof |
| 02/10/2011 | US20110033923 Marker for stem cells and its use |
| 02/10/2011 | US20110033921 Bardet-biedl susceptibility gene and uses thereof |
| 02/10/2011 | US20110033895 Method For Producing Human Antibodies With Properties Of Agonist, Antagonist, or Inverse Agonist |
| 02/10/2011 | US20110033892 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof |
| 02/10/2011 | US20110033884 PD-1, A Receptor for B7-4, and Uses Therefor |
| 02/10/2011 | US20110033877 Method for Evaluation or Selection of Adiponectin Secretion Regulator |
| 02/10/2011 | US20110033876 Method for diagnosing pulmonary artery hypertension |
| 02/10/2011 | US20110033875 Glycoprotein cancer biomarker |
| 02/10/2011 | US20110033874 Biomarkers |
| 02/10/2011 | US20110033873 Proteinic marker for early diagnosis of liver cancer |
| 02/10/2011 | US20110033872 Method and apparatus for detecting undesired measurement conditions |
| 02/10/2011 | US20110033871 Method for the determination of trichinella infections and diagnostic composition for such methods |
| 02/10/2011 | US20110033870 Hybridoma producing antibodies to lawsonia intracellularis |
| 02/10/2011 | US20110033869 Enzyme Triggered Redox Altering Chemical Elimination (E-Trace) Immunoassay |
| 02/10/2011 | US20110033868 Use of a nitrated protein or peptide sequence for the implementation of a method of diagnosis |
| 02/10/2011 | US20110033867 Use of biomarkers for detecting ovarian cancer |
| 02/10/2011 | US20110033866 Resonance Energy Transfer Assay with Cleavage Sequence and Spacer |
| 02/10/2011 | US20110033865 Novel method for diagnosing pregnancy-related complications |
| 02/10/2011 | US20110033856 Methods relating to aromatase inhibitor pharmacogenetics |
| 02/10/2011 | US20110033855 Method for quantifying target nucleic acid molecules and kit for quantifying target nucleic acid molecules |
| 02/10/2011 | US20110033853 CSNKS As Modifiers of the RAC Pathway and Methods of Use |
| 02/10/2011 | US20110033850 Compositions and methods for the identification of inhibitors of retroviral infection |
| 02/10/2011 | US20110033849 Ovine identification method |
| 02/10/2011 | US20110033848 Epigenetic methods |
| 02/10/2011 | US20110033847 Methods for the characterization of microorganisms on solid or semi-solid media |
| 02/10/2011 | US20110033844 Use of lysosomal carboxypeptidase c (prcp) as a therapeutic or diagnostic target |
| 02/10/2011 | US20110033843 Method for in vitro testing of compounds for assessing therapeutic value in the treatment of multiple sclerosis and other diseases wherein foamy cells are involved in the disease etiology |